Zentek (CVE:ZEN) Shares Up 21.5% – Should You Buy?

Zentek Ltd. (CVE:ZENGet Free Report) shares traded up 21.5% on Thursday . The stock traded as high as C$1.70 and last traded at C$1.64. 147,738 shares traded hands during mid-day trading, an increase of 343% from the average session volume of 33,375 shares. The stock had previously closed at C$1.35.

Zentek Stock Up 21.5 %

The company’s 50 day moving average price is C$1.48 and its two-hundred day moving average price is C$1.33. The company has a current ratio of 2.06, a quick ratio of 7.59 and a debt-to-equity ratio of 4.97. The firm has a market cap of C$168.48 million, a PE ratio of -15.48 and a beta of 0.77.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

See Also

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.